🔄
top of page

Probiotics for Digestive Health: What to Know Before Choosing One

11 hours ago
16 min read

Clinically reviewed by Linda Spirou, BHSc (Naturopathy)


Certified Healthy Gut Practitioner — Microbiome Restoration Center


Certified Microbiome Analyst — Microbiome Restoration Center


Linda Spirou — Certified Healthy Gut Practitioner, Microbiome Restoration Center

Linda Spirou — Certified Microbiome Analyst, Microbiome Restoration Center


Before you buy another probiotic, ask yourself these questions


What happens if the probiotic you choose doesn't work?


Does the exact strain matter — or is seeing Lactobacillus or Bifidobacterium on the label enough?


Does a bigger number of CFUs actually mean you're buying a better probiotic?


What are you trying to change in the first place — bloating, constipation, IBS symptoms, bowel regularity, antibiotic-associated diarrhoea or something else?


Has the exact strain you're considering actually been studied for that outcome?


Could fibre, diet or a prebiotic be more relevant than another probiotic?


If your symptoms are persistent, changing or difficult to explain, have they been medically assessed?


And before you buy one more product: are you choosing it based on enough information — or are you still guessing?


This is where probiotics for digestive health become more complicated than a shelf full of brightly coloured bottles.


The most useful question usually isn't:


“What is the best probiotic?”

It's:


“What am I actually trying to influence, and does this exact probiotic have evidence for doing that?”

International probiotic guidance emphasises that benefits should generally be linked to a specific strain or tested strain combination, at an effective dose, for a particular outcome.


There is no universal probiotic strain, dose or CFU number that is best for everyone.[1]


And sometimes, a probiotic may not be the most relevant first step at all.


Are probiotics actually good for digestive health?


Sometimes.


But “digestive health” isn't one single clinical outcome.


A person taking a probiotic to reduce the risk of antibiotic-associated diarrhoea is asking a very different scientific question from someone taking one for constipation, IBS, bloating or general wellness.


Research suggests certain probiotics can be useful in particular circumstances, but the evidence varies considerably depending on:


  • the condition or symptom being targeted

  • the exact microorganism and strain

  • the dose

  • the formulation

  • the population being studied

  • how long the probiotic is taken

  • the outcome researchers actually measured


This is why statements such as “probiotics are good for your gut” can be too broad to help you make a useful decision.


For IBS, for example, some specific strains have shown promising results, yet major gastroenterology guidelines remain cautious because studies differ greatly in their quality, strains, doses and outcomes.[35]


For antibiotic-associated diarrhoea, the overall evidence is more convincing, although it is still dependent on the probiotic, timing and population.[1113]


For otherwise healthy people wanting vaguely defined “better gut health”, there is much less justification for assuming everyone benefits from routine supplementation.[1]


The details matter.


Why the exact probiotic strain matters


One of the most important things to understand about probiotics is the difference between:


Genus → species → strain


Imagine someone's name:


Smith → John → John Smith #35624


Knowing only the family name wouldn't tell you exactly who you're dealing with.


Probiotics work similarly.


For example:


Bifidobacterium longum 35624


contains:


  • Genus: Bifidobacterium

  • Species: longum

  • Strain: 35624


Two probiotics belonging to the same species can have different characteristics and different clinical evidence.


So if research shows that one specific strain has been studied for an IBS outcome, you cannot automatically assume every other Bifidobacterium longum product produces the same effect.


This principle is central to modern probiotic science.[1,2]


One species can contain very different strains


This is also why reading only the front of the bottle can be misleading.


A label saying:


“Contains Lactobacillus and Bifidobacterium”

doesn't tell you nearly as much as:


“Contains Lactiplantibacillus plantarum 299v at X CFU.”

The strain gives you something that can actually be compared against published research.


The next question becomes:


Has that strain been studied for what you're trying to improve?

Which probiotics have evidence for different digestive problems?


There isn't a scientifically defensible universal list of the “Top 5 probiotics”.


A better approach is to look at strain–outcome combinations.


Probiotic strain

Digestive area studied

Current evidence picture

Important limitation

Bifidobacterium longum 35624

IBS symptoms, abdominal discomfort, bloating

Promising strain-specific evidence

Not everyone responds; results and dose matter

Lactiplantibacillus plantarum 299v

IBS, abdominal pain, bloating

Mixed but potentially useful evidence

Positive and negative trials exist

Lacticaseibacillus rhamnosus GG (LGG)

Antibiotic-associated diarrhoea

One of the better-studied strains

Evidence differs between adults and children

Saccharomyces boulardii

Antibiotic-associated diarrhoea and other diarrhoeal settings

Moderate evidence in selected contexts

Products/strains and patient safety matter

Bifidobacterium animalis subsp. lactis BB-12

Bowel-movement frequency

Some evidence for bowel regularity

Regularity research is not identical to chronic constipation treatment

B. animalis subsp. lactis HN019

Transit and constipation

Earlier promise, later negative trials

A good example of evidence changing over time

Saccharomyces cerevisiae CNCM I-3856

IBS pain/global symptoms

Some outcome-specific evidence

Cannot be generalised to other Saccharomyces strains


The key lesson isn't that everyone should take one of these.


It's that the name on the strain matters because the research belongs to the strain that was actually studied.


IBS and bloating


IBS illustrates why probiotic research can become confusing very quickly.


A 2023 systematic review and meta-analysis examined 82 randomised controlled trials involving more than 10,000 participants and found signals of benefit for certain probiotics across outcomes including global IBS symptoms, abdominal pain and bloating.[5]


But there was substantial variation between studies.


Different trials used:


  • different IBS definitions

  • different IBS subtypes

  • different strains

  • different probiotic combinations

  • different doses

  • different outcome measures

  • different treatment durations


Most evidence assessments remained low or very low certainty.[5]


The American College of Gastroenterology has therefore suggested against probiotics as a broad class for global IBS symptoms because of very low-quality evidence, while the American Gastroenterological Association has also taken a cautious position.[3,4]


That doesn't mean no probiotic can ever help someone with IBS.


It means:


“Probiotics work for IBS” is too broad a statement.

Some specific strains have shown benefits for some outcomes.


For example, B. longum 35624 has been studied for IBS symptoms, including abdominal discomfort and bloating.[6]


L. plantarum 299v has also been studied, but findings have not been uniformly positive.[7]


So if you're standing in a chemist asking:


“Which probiotic helps bloating?”

the scientifically responsible answer isn't simply a brand name.


It starts with:


What is causing the bloating?

What else is happening clinically?

And what exact strain has evidence for the outcome you're trying to change?

Constipation and bowel regularity


There is evidence suggesting probiotics may produce modest improvements in some constipation outcomes.


A 2014 systematic review found an overall increase of approximately 1.3 bowel movements per week and a reduction in whole-gut transit time, although the studies were heterogeneous and had methodological limitations.[8]


A later 2020 meta-analysis also reported improvements in stool frequency and transit time.[9]


But there's an important lesson here.


Bifidobacterium animalis subsp. lactis HN019 had earlier research suggesting potential benefits for bowel transit.


Then larger, more recent research challenged that expectation.


A 2024 triple-blind randomised trial found HN019 was not superior to placebo for the primary functional-constipation outcome.[10]


That makes HN019 a particularly useful example of how probiotic decisions should work:


A strain can have promising early research and still fail to demonstrate the expected benefit in later, larger studies.

Evidence should be updated — not merely accumulated.

BB-12 has also been investigated for bowel-movement frequency, but it's important to distinguish helping someone with low bowel frequency from treating clinically defined chronic constipation.


Again, the outcome matters.


Diarrhoea and antibiotics


Antibiotic-associated diarrhoea is one of the digestive areas where probiotics have a stronger overall evidence base.


A 2021 meta-analysis of 36 studies involving 9,312 adults found that probiotics reduced antibiotic-associated diarrhoea overall, although the size of the effect varied between studies.[11]


LGG and Saccharomyces boulardii are among the organisms that have been studied extensively in this area.[12,13]


But there's another distinction worth understanding.


Question 1:


Can a particular probiotic reduce the risk of antibiotic-associated diarrhoea?


Question 2:


Will taking that probiotic restore my microbiome to exactly what it was before antibiotics?


These are not the same scientific question.


“Take probiotics to restore your gut flora after antibiotics”

is too simplistic.


Preventing diarrhoea and restoring an individual's entire microbiome are different outcomes.


How to read a probiotic label


Before choosing a probiotic, look beyond the number on the front.


A useful label should allow you to identify:


What to look for

Why it matters

Genus

Broad microbial classification

Species

Narrows the organism further

Exact strain

Allows comparison with clinical research

CFU count

Indicates viable organism quantity

Evidence-supported dose

Lets you compare the product with the amount actually studied

Storage instructions

Viability can depend on appropriate storage

Expiry / end-of-shelf-life potency

The organisms need to remain viable through the relevant period

Other strains/ingredients

Helps you understand the actual formulation


Does a higher CFU count mean a better probiotic?


No — not automatically.


CFU means colony-forming units.


Marketing can make it tempting to assume:


50 billion > 10 billion > 1 billion


therefore:


more = better.


But probiotic research doesn't work that way.


The appropriate dose depends on the strain, formulation and outcome being studied.


World Gastroenterology Organisation guidance specifically notes that probiotic doses vary substantially and that a universal required dose cannot be stated.[1]


One well-known trial involving B. longum 35624 actually demonstrated benefit at one tested dose while the other doses did not produce the same result.[6]


So:


A higher CFU count doesn't automatically mean better evidence.

The better question is:


Is this approximately the dose that was shown to work for this strain and this outcome?

Are more probiotic strains better?


Again, not automatically.


A bottle containing:


15 probiotic strains


isn't scientifically superior simply because another contains:


3 strains.


A multi-strain probiotic can be useful when that specific combination has evidence.


But the length of the ingredient list isn't evidence in itself.


More isn't necessarily better.


Better-supported is better-supported.


Practitioner-only probiotics versus chemist probiotics


The phrase “practitioner only” can make a supplement sound inherently more clinical.


But where a product is sold isn't itself an evidence grade.


The more useful questions are:


  • Does it identify the exact strain?

  • Is the dose clear?

  • Has the strain or combination been studied for the intended outcome?

  • Is viability maintained appropriately?

  • Does the formulation match the research?

  • Is someone recommending it for a defined reason?


A practitioner-only product could potentially meet these criteria.


So could a retail product.


The important distinction is not simply:


Practitioner shelf vs chemist shelf.

It's:


Evidence vs assumption.

Not sure what you're actually trying to target?


Before changing another supplement, it may help to clarify your symptoms, what has already been tried and what outcome you actually want to change.


A probiotic should ideally have a reason for being there, rather than simply becoming another item in a growing supplement cupboard.


Could fibre or a prebiotic matter more?


Probiotics receive enormous attention, but the microbes already living in your gut also interact continuously with what you eat.


That makes diet and fibre highly relevant.


A prebiotic isn't simply any fibre or something that vaguely “feeds good bacteria”.


The accepted scientific definition describes a substrate that is selectively utilised by host microorganisms and confers a health benefit.[15]


Different fibres behave differently.


Fibre / prebiotic

What makes it different

Potential digestive relevance

Important consideration

Psyllium

Gel-forming soluble fibre

Constipation and IBS bowel-function support

Fluid intake and dose matter

PHGG

Fermentable soluble fibre

Studied for bowel function and some IBS symptoms

Response and tolerance vary

GOS

Prebiotic with bifidogenic effects

Can alter microbiota composition

May increase gas/bloating in some people

Inulin/FOS

Highly fermentable and bifidogenic

Strong evidence for increasing bifidobacteria

Microbiome change does not guarantee symptom improvement

Resistant starch

Fermented by gut microbes

Can alter microbial and metabolic profiles

Responses vary between people and starch types


This means:


not every fibre supplement is interchangeable.

For someone experiencing constipation, one fibre may make sense.


For someone experiencing substantial fermentative bloating, another approach might be more tolerable.


And increasing a bacterial group on a microbiome report doesn't automatically mean symptoms will improve.


What about taking a probiotic and prebiotic together?


That combination is often called a synbiotic.


But simply putting a probiotic and prebiotic together does not prove they work synergistically.


Scientific consensus distinguishes between combinations that are simply complementary and combinations designed so the substrate specifically supports the co-administered microorganism.[16]


So once again:


the combination needs evidence.

Fermented foods versus probiotic supplements


Fermented foods can form part of a healthy diet, but fermented doesn't automatically mean probiotic.


Foods such as yoghurt and kefir may contain live cultures depending on the product.


Kimchi, sauerkraut and other fermented vegetables can also contain microorganisms.


But processing, storage and preparation can change whether organisms remain alive.


And unlike a clinical trial of a standardised probiotic strain, most fermented food often do not provide:


  • an exact clinically studied strain

  • a known CFU dose

  • a standardised formulation

  • evidence for a particular digestive outcome


So:


“Just eat fermented foods instead”

is no more universally correct than:


“Everyone should take a probiotic.”

What if probiotics don't work?


This is where the conversation becomes more important than simply choosing another bottle.


Persistent digestive symptoms can have many potential explanations.


A probiotic is only one possible intervention within a wider clinical and dietary picture.


People may seek gut-health support for concerns including:


  • bloating

  • constipation

  • diarrhoea

  • abdominal or stomach pain

  • food sensitivities

  • SIBO

  • suspected LIBO

  • digestive symptoms following an overseas infection

  • symptoms after gastroenteritis

  • symptoms following antibiotic treatment

  • concerns after previous H. pylori

  • persistent symptoms without an obvious pattern


People may also report issues such as poor sleep, brain fog, skin concerns or difficulty managing their weight.


That does not mean those symptoms are necessarily caused by the microbiome.


They're simply part of the wider clinical presentation that may need to be considered.


Other relevant history might include:


  • recent or repeated antibiotics

  • PPI use

  • diet

  • fibre intake

  • bowel habits

  • medications

  • stress

  • previous infections

  • previous testing

  • previous treatments

  • what has and hasn't helped


The objective isn't to turn every symptom into a microbiome problem.


It's to avoid reducing a complicated presentation to:


“Which probiotic should I buy?”

When digestive symptoms should be medically assessed


A supplement experiment should never delay appropriate medical care.


Speak with a GP or other appropriate healthcare professional if you experience concerning symptoms such as:


  • gastrointestinal bleeding or blood in the stool

  • unexplained weight loss

  • persistent vomiting

  • severe or escalating abdominal pain

  • possible anaemia

  • persistent fever

  • a significant or unexplained change in bowel habits

  • a concerning personal or family medical history


Appropriate investigation comes before trying to solve every problem with probiotics.


Gut-health care does not need to exist separately from conventional medical care.


Where appropriate, involvement from a GP, gastroenterologist or another healthcare professional may be an important part of the picture.


Is guessing becoming expensive?


Imagine spending:


$200 per month on supplements.


That's:


$1,200 over six months.


And:


$2,400 over twelve months.


That isn't an estimate of what the average Australian spends.


It's simply an example of how repeated experimentation can add up.


The issue isn't that supplements are inherently a waste of money.


The issue is whether each product has:


  • a defined reason for being used

  • an outcome you are trying to change

  • evidence supporting that rationale

  • a point at which you review whether it is actually helping


Otherwise it's easy to move from:


probiotic → new probiotic → prebiotic → fibre powder → another supplement → new diet


without ever becoming clearer about what you're trying to achieve.


Would a gut microbiome test add useful information?


Sometimes it may.


But this is an area where expectations need to stay realistic.


Modern stool microbiome tests can provide substantially more information than older culture-based methods.


Depending on the technology, testing may describe:


  • microbial DNA

  • relative microbial composition

  • microbial diversity

  • certain pathogens

  • genes and pathways representing functional potential

  • additional gastrointestinal markers where specific laboratory assays are included


But current international consensus also emphasises that the routine clinical usefulness of microbiome testing remains incompletely established, and interpretation can run ahead of the evidence.[18]


A microbiome test should therefore not be presented as a machine that tells you:


“Here is exactly what is wrong and exactly which probiotic you need.”

It can't reliably do that.


What stool microbiome testing can — and cannot — tell you


A microbiome test may help generate useful questions.


For example:


  • Is there a finding worth investigating further?

  • Are validated gastrointestinal markers abnormal?

  • Is a pathogen detected?

  • Could diet or medication be influencing the result?

  • Does the microbial finding make sense alongside the person's symptoms?

  • Would the result meaningfully change a treatment decision?


But microbiome testing cannot currently, on its own:


  • diagnose IBS from a microbial pattern

  • prove one microorganism caused someone's symptoms

  • identify the perfect probiotic for every person

  • perfectly prescribe an individualised fibre

  • prove that changing one reported organism will improve symptoms

  • describe everything the gut microbiome is doing in real time


That's an important distinction.


Different gut tests measure different things


Method

What it looks for

Strength

Limitation

Culture

Organisms that grow under laboratory conditions

Useful for selected viable organisms/pathogens

Misses much of the wider microbial ecosystem

Targeted PCR

Specific DNA/RNA targets

Sensitive and useful when the target is known

Only finds what the assay is designed to look for

16S sequencing

Bacterial/archaeal community markers

Useful community profiling

Usually lower species/strain resolution

Shotgun metagenomics

Broad microbial DNA

Greater species-level detail and functional potential information

More complex; results depend on laboratory and bioinformatics methods


This matters because two companies can both offer something called a “gut microbiome test” while using very different technologies.


A look inside a Microba report


Microba's current Microbiome Explorer platform uses metagenomic profiling, with some testing tiers also incorporating gastrointestinal-marker and pathogen testing.


Its reporting can contain considerably more information than what you'll find on the back of a probiotic bottle.


But more information isn't automatically the same as more certainty.


The useful question is:


Which findings are meaningful enough to actually change a decision?

What about Microba's Clinical Insights?


Microba also provides structured clinical insights and evidence-grading features.


This can make a microbiome report easier to navigate, but the evidence grade still needs to be understood in context.


Microba has published analytical validation work supporting aspects of its metagenomic taxonomic profiling methodology.[19]


That is useful evidence about the analytical platform.


It should not be interpreted as proof that microbiome testing can perfectly personalise probiotic treatment or guarantee improved clinical outcomes.


Do you need a probiotic, broader assessment, or neither?


A simple way to think about the decision is:


1. What are you trying to improve?


If you don't have a defined outcome, clarify the goal before buying another supplement.


2. Do you have persistent or concerning symptoms?


If yes, appropriate medical assessment may come first.


3. Is there evidence for the exact strain or combination you're considering?


Look at the organism, strain, dose and outcome.


4. Could something simpler be more relevant?


Consider diet, fibre, medication review or another appropriate intervention.


5. If you trial the probiotic, how will you know whether it helped?


Use a defined, time-limited outcome where appropriate.


6. If it doesn't help, will you simply buy another one?


Or would it make more sense to reconsider the working hypothesis?


7. Would broader assessment add useful information?


If the presentation is persistent or complicated, discussing it with an appropriately qualified practitioner may help organise the next steps.


Assessment is an option when uncertainty matters — not a requirement for everybody who considers a probiotic.


Questions to ask a gut-health practitioner


If you've decided you want help, don't be afraid to ask questions.


For example:


  • What are your professional qualifications?

  • How much of your clinical work involves gastrointestinal health?

  • What additional gut-health education have you completed?

  • Do you assess probiotic evidence at strain level?

  • If you recommend microbiome testing, what methodology does the test use?

  • What can that test reliably tell me?

  • How will the result change what we do?

  • Why are you recommending each supplement?

  • What happens if I don't respond as expected?

  • How will the plan be reviewed?

  • When would you recommend I return to my GP or see a gastroenterologist?


A qualification or certification can demonstrate additional training.


It should not be confused with medical-specialist status.


How The Gut Guy approaches personalised gut health support


The principle behind a more structured approach is simple:


Each intervention should have a reason.

Rather than starting with:


“Which probiotic should we prescribe?”

the process can begin with:


Understand → assess → decide whether testing adds value → interpret → plan → review and adjust


Not every person needs microbiome testing.


Not everyone needs a probiotic.


And not every person requires the same type of support.


Where testing is considered, it should ideally be because the result is expected to answer a useful question or potentially change a decision — not simply because more data sounds better.


Before moving through any stage of care, you should understand:


  • what is being recommended

  • why it is being recommended

  • what is included

  • what it costs

  • what the next decision will be


When the next step is unclear, assessment can sometimes be more useful than another guess.


Ready to talk through your next step?


First step is a complimentary gut health phone call with The Gut Guy himself.


These calls are pretty basic.


It’s really more for The Gut Guy to understand more about your symptoms, past treatments, your health goals and how you’re possibly wanting to achieve your goals.


And towards the end of the call, if you feel like our solution might be what you’re looking for, we can talk about possible next steps.



Clinical Reviewer


Linda Spirou


  • Bachelor of Health Science BHSc (Naturopathy)

  • Graduate Certificate in Evidence Based Complimentary Medicines

  • Completed the Monash University ‘Low FODMAP Diet for IBS’ online training course for health professionals

  • SIBO Doctor Approved Practitioner

  • Certified Healthy Gut Practitioner — Microbiome Restoration Center

  • Certified Microbiome Analyst — Microbiome Restoration Center


Important information


This article is educational information and does not provide individual medical advice or diagnosis.


Clinical review is intended to improve the accuracy and appropriateness of the published information; it does not replace assessment by a GP, gastroenterologist or other appropriate healthcare professional where required.


References


1. Guarner F, Sanders ME, Szajewska H, et al. World Gastroenterology Organisation Global Guidelines: Probiotics and Prebiotics. 2023.


2. Hill C, Guarner F, Reid G, et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology. 2014;11:506–514. doi:10.1038/nrgastro.2014.66.


3. Su GL, Ko CW, Bercik P, et al. AGA Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders. Gastroenterology. 2020;159(2):697–705. doi:10.1053/j.gastro.2020.05.059.


4. Lacy BE, Pimentel M, Brenner DM, et al. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. American Journal of Gastroenterology. 2021;116:17–44. doi:10.14309/ajg.0000000000001036.


5. Ford AC, et al. Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis. Gastroenterology. 2023. doi:10.1053/j.gastro.2023.07.018.


6. Whorwell PJ, Altringer L, Morel J, et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. American Journal of Gastroenterology. 2006. doi:10.1111/j.1572-0241.2006.00734.x.


7. Niedzielin K, Kordecki H, Birkenfeld B. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. European Journal of Gastroenterology & Hepatology. 2001;13(10):1143–1147. doi:10.1097/00042737-200110000-00004.


8. Dimidi E, Christodoulides S, Fragkos KC, Scott SM, Whelan K. The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials. American Journal of Clinical Nutrition. 2014;100(4):1075–1084. doi:10.3945/ajcn.114.089151.


9. Zhang C, Jiang J, Tian F, et al. Meta-analysis of randomized controlled trials of the effects of probiotics on functional constipation in adults. Clinical Nutrition. 2020;39(10):2960–2969. doi:10.1016/j.clnu.2020.01.005.


10. Cheng J, Gao C, Ala-Jaakkola R, et al. Eight-Week Supplementation With Bifidobacterium lactis HN019 and Functional Constipation: A Randomized Clinical Trial. JAMA Network Open. 2024;7(10):e2436888. doi:10.1001/jamanetworkopen.2024.36888.


11. Liao W, Chen C, Wen T, Zhao Q. Probiotics for the Prevention of Antibiotic-associated Diarrhea in Adults: A Meta-analysis of Randomized Placebo-Controlled Trials. Journal of Clinical Gastroenterology. 2021. doi:10.1097/MCG.0000000000001464.


12. Szajewska H, Kołodziej M. Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults. Alimentary Pharmacology & Therapeutics. 2015. doi:10.1111/apt.13404.


13. Szajewska H, Kołodziej M. Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Alimentary Pharmacology & Therapeutics. 2015. doi:10.1111/apt.13344.


15. Gibson GR, Hutkins R, Sanders ME, et al. The ISAPP consensus statement on the definition and scope of prebiotics. Nature Reviews Gastroenterology & Hepatology. 2017;14(8):491–502. doi:10.1038/nrgastro.2017.75.


16. Swanson KS, Gibson GR, Hutkins R, et al. The ISAPP consensus statement on the definition and scope of synbiotics. Nature Reviews Gastroenterology & Hepatology. 2020;17(11):687–701. doi:10.1038/s41575-020-0344-2.


17. Wilson B, Rossi M, Dimidi E, Whelan K. Prebiotics in irritable bowel syndrome and other functional bowel disorders in adults: a systematic review and meta-analysis of randomized controlled trials. American Journal of Clinical Nutrition. 2019. doi:10.1093/ajcn/nqy376.


18. Porcari S, et al. International consensus statement on microbiome testing in clinical practice. Lancet Gastroenterology & Hepatology. 2025;10(2):154–167. doi:10.1016/S2468-1253(24)00311-X.


19. Parks DH, Rigato F, Vera-Wolf P, Krause L, Hugenholtz P, Tyson GW, Wood DLA. Evaluation of the Microba Community Profiler for Taxonomic Profiling of Metagenomic Datasets From the Human Gut Microbiome. Frontiers in Microbiology. 2021;12:643682. doi:10.3389/fmicb.2021.643682.


20. Marco ML, et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the definition and scope of gut health. Nature Reviews Gastroenterology & Hepatology. 2026;23(5):432–448. doi:10.1038/s41575-026-01176-x.


Comments


bottom of page